Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Arkansas.
Press releases published on June 17, 2025

Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, …

Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF and plasma exposures reinforce VTX3232’s potential as a once-daily oral therapy for neurodegenerative diseases VTX3232 …

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial support vHOT as early indicator of …

Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it was …

Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally Exhibiting at European Society of Organ Transplantation (ESOT) …

Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria
– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure, and a 7.5 mmHg placebo-adjusted reduction (p=0.0024) at four weeks – – Lorundrostat showed a clinically meaningful reduction in …

ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
CAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with …

BCC Mining is a one-stop cloud mining platform that supports multiple cryptocurrencies and obtains potential profits
Philadelphia, PA, June 17, 2025 (GLOBE NEWSWIRE) -- Crypto News: BCC Mining, the world's largest cloud mining platform, officially announced deep integration with multiple currencies: users can directly use multiple digital currencies for cloud mining. …

Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma
LYL314 demonstrated robust clinical responses, with an 88% overall response rate and a 72% complete response rate in patients treated in the third- or later-line setting (N = 25) 71% of patients with complete response remained in complete response at ≥ 6 …

Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients
- 94% OS and 72% PFS observed at 6 months for atebimetinib (IMM-1-104) in combination with modified Gemcitabine/nab-paclitaxel (mGnP), N=34; median OS and PFS not yet reached - - Striking tumor reductions with 39% overall response rate and 81% disease …

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42
HUNTSVILLE, June 17, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today congratulates its strategic partner …

Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
GROTON, Conn., June 17, 2025 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc., a clinical-stage biotechnology company today announced two major milestones that could change the way we protect brains from the damage caused by concussions and repeat head …

AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025
DUBLIN and BERWYN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- We are proud to announce that AscellaHealth has been awarded Gold in the Business Change and Transformation Excellence category at the Industry Eagles Awards 2025, held on 5th June 2025 at The …

Les bons réflexes après une cyberattaque et pour protéger son SI
Une cyberattaque peut bouleverser bien plus que les systèmes informatiques d’une entreprise. Elle affecte son image, ses clients, son fonctionnement quotidien. Pour une TPE ou une PME, ce genre d’incident peut mettre en péril toute l’activité si une …

Stordata poursuit son expansion en 2025 avec de nouvelles embauches
L’entreprise de services numériques Stordata, expert reconnu sur le marché des solutions de gestion de données et de la transformation SI, poursuit sa dynamique de croissance et annonce l’ouverture de 20 postes en 2025 pour soutenir son développement dans …

TORRAS Announces the Launch of Q3 Air Series: A Refined Evolution in Stand-Based Phone Case Design
LOS ANGELES, June 17, 2025 (GLOBE NEWSWIRE) -- TORRAS, a longstanding innovator in the stand-style phone case category, today officially introduced its latest model—the Q3 Air Series. As the third-generation iteration in TORRAS’s flagship lineup, the Q3 …

Aurora Mobile's EngageLab Empowers Tea Beverage Brand Global Expansion with Customer Engagement Solution
SHENZHEN, China, June 17, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced that its subsidiary EngageLab, a …

EngageLab Empowers Tea Beverage Brand Global Expansion with Customer Engagement Solution
SINGAPORE, June 17, 2025 (GLOBE NEWSWIRE) -- EngageLab, a leading omni-channel customer engagement platform provider, is proud to announce its successful partnership with a prominent Chinese tea beverage brand, supporting the company's global expansion …

Llusern Scientific Announces ISO 13485 Certification for its Point-of-Care Diagnostics System for Urinary Tract Infections
CARDIFF, United Kingdom, June 17, 2025 (GLOBE NEWSWIRE) -- Llusern Scientific, a point-of-care diagnostics company, announces it has been awarded ISO 13485 certification for its Lodestar DX testing system, a rapid molecular diagnostic platform for urinary …

Infomaniak macht E-Mail-Verschlüsselung für alle Nutzer*innen kostenlos
Nach der Lancierung von my kSuite, der kostenlosen Lösung für unabhängige E-Mail-Dienste und einen unabhängigen Online-Arbeitsbereich, erreicht der Schweizer Cloud-Anbieter Infomaniak einen weiteren Meilenstein: Ab sofort ist die Verschlüsselung von E- …